Current role
Dr. Debora Barton, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Debora Barton, M.D.
TScan Therapeutics, Inc. reported in an 8-K filed July 7, 2022 that Dr. Debora Barton, M.D. was appointed Chief Medical Officer, effective July 5, 2022.
“On July 7, 2022, TScan Therapeutics, Inc. (the "Company"), announced the appointment of Dr. Debora Barton, M.D., to serve as the Company's Chief Medical Officer, effective July 5, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
TScan Therapeutics, Inc. (TCRX)
SEC 8-K
Current2022-07-05–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at TScan Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Gavin MacBeath CEO, CFO
- Stephen Biggar Chairman
- Brian Silver CFO
- Jason A. Amello Chief Accounting Officer, Board Member
- Leiden Dworak Chief Accounting Officer
- Barbara Klencke, M.D. Board Member
- Chrystal Louis Board Member
- Garry A. Nicholson Board Member
- Katina Dorton Board Member
- R. Keith Woods Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.